Stocks · Health care · Pharmaceutical Preparations

Protagonist Therapeutics, Inc

PTGX Clue Score48
United States Fiscal year ends December CIK 0001377121 Results filed 5 Nov 2026

What the insiders did Net selling

By person

17 insiders · 164 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Dinesh V Ph D Patel
President and CEO
$168.50K (2)
$67.29M (32) scheduled
−$67.12M
522,968
$74.15M
+257.5%
Asif Ali
Chief Financial Officer
—
$18.60M (18) scheduled
−$18.60M
59,003
$8.37M
+6,613%
Arturo Md Molina
Chief Medical Officer
—
$8.84M (16) scheduled
−$8.84M
84,115
$11.93M
—
William D. Waddill
Director
—
$7.66M (13) scheduled
−$7.66M
7,825
$1.11M
—
Bryan Giraudo
Director
$110.19K (2)
$5.92M (4) scheduled
−$5.81M
12,695
$1.80M
+27.0%
Suneel Gupta
Chief Development Officer
$153.90K (1)
$5.76M (3) scheduled
−$5.61M
267,433
$37.92M
+1,250%
Canaan X L.p.
10% owner
—
$4.04M (13)
−$4.04M
2,116,552
$300.08M
−13.7%
Harold E Selick
Director
$80.40K (1)
$2.52M (1) scheduled
−$2.44M
60,845
$8.63M
—
Lewis T Williams
Director
—
$1.48M (1) scheduled
−$1.48M
7,825
$1.11M
—
David Y Liu
Chief R&D Strategy Officer
—
$1.13M (13) scheduled
−$1.13M
167,590
$23.76M
+1,328%
Richard S. Shames
Chief Medical Officer
—
$215.91K (7) scheduled
−$215.91K
32,021
$4.54M
+493.8%
Sarah B. Noonberg
Director
—
$212.56K (3) scheduled
−$212.56K
0
$0.00
—
Thomas P. O'Neil
Chief Financial Officer
—
$160.00K (1) scheduled
−$160.00K
30,560
$4.33M
+783.2%
Chaitan Phd Khosla
Director
—
$42.95K (1) scheduled
−$42.95K
0
$0.00
—
Donald A. Kalkofen
Chief Financial Officer
$5.99K (2)
—
+$5.99K
18,521
$2.63M
+689.5%
Samuel R Saks
Chief Medical Officer
—
—
—
14,000
$1.98M
—
Sarah A O'Dowd
Director
—
—
—
7,825
$1.11M
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.